These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 31735642)

  • 41. Keeping our eyes on CRISPR: the "Atlas" of gene editing.
    Wang W; Hou J; Zheng N; Wang X; Zhang J
    Cell Biol Toxicol; 2019 Aug; 35(4):285-288. PubMed ID: 31165372
    [No Abstract]   [Full Text] [Related]  

  • 42. Characterization and applications of Type I CRISPR-Cas systems.
    Hidalgo-Cantabrana C; Barrangou R
    Biochem Soc Trans; 2020 Feb; 48(1):15-23. PubMed ID: 31922192
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Type III CRISPR-Cas System: Introduction And Its Application for Genetic Manipulations.
    Liu T; Pan S; Li Y; Peng N; She Q
    Curr Issues Mol Biol; 2018; 26():1-14. PubMed ID: 28879852
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Structural Basis for the Canonical and Non-canonical PAM Recognition by CRISPR-Cpf1.
    Yamano T; Zetsche B; Ishitani R; Zhang F; Nishimasu H; Nureki O
    Mol Cell; 2017 Aug; 67(4):633-645.e3. PubMed ID: 28781234
    [TBL] [Abstract][Full Text] [Related]  

  • 45. CRISPRCasdb a successor of CRISPRdb containing CRISPR arrays and cas genes from complete genome sequences, and tools to download and query lists of repeats and spacers.
    Pourcel C; Touchon M; Villeriot N; Vernadet JP; Couvin D; Toffano-Nioche C; Vergnaud G
    Nucleic Acids Res; 2020 Jan; 48(D1):D535-D544. PubMed ID: 31624845
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A detailed cell-free transcription-translation-based assay to decipher CRISPR protospacer-adjacent motifs.
    Maxwell CS; Jacobsen T; Marshall R; Noireaux V; Beisel CL
    Methods; 2018 Jul; 143():48-57. PubMed ID: 29486239
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cas3-stimulated runaway replication of modified ColE1 plasmids in Escherichia coli is temperature dependent.
    Radovčić M; Čulo A; Ivančić-Baće I
    FEMS Microbiol Lett; 2019 May; 366(9):. PubMed ID: 31095294
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Anti-CRISPR AcrIE2 Binds the Type I-E CRISPR-Cas Complex But Does Not Block DNA Binding.
    Mejdani M; Pawluk A; Maxwell KL; Davidson AR
    J Mol Biol; 2021 Feb; 433(3):166759. PubMed ID: 33338493
    [TBL] [Abstract][Full Text] [Related]  

  • 49. DNA Targeting by a Minimal CRISPR RNA-Guided Cascade.
    Hochstrasser ML; Taylor DW; Kornfeld JE; Nogales E; Doudna JA
    Mol Cell; 2016 Sep; 63(5):840-51. PubMed ID: 27588603
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Two distinct DNA binding modes guide dual roles of a CRISPR-Cas protein complex.
    Blosser TR; Loeff L; Westra ER; Vlot M; Künne T; Sobota M; Dekker C; Brouns SJJ; Joo C
    Mol Cell; 2015 Apr; 58(1):60-70. PubMed ID: 25752578
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Modulating the Cascade architecture of a minimal Type I-F CRISPR-Cas system.
    Gleditzsch D; Müller-Esparza H; Pausch P; Sharma K; Dwarakanath S; Urlaub H; Bange G; Randau L
    Nucleic Acids Res; 2016 Jul; 44(12):5872-82. PubMed ID: 27216815
    [TBL] [Abstract][Full Text] [Related]  

  • 52. An Isothermal Method for Sensitive Detection of Mycobacterium tuberculosis Complex Using Clustered Regularly Interspaced Short Palindromic Repeats/Cas12a Cis and Trans Cleavage.
    Xu H; Zhang X; Cai Z; Dong X; Chen G; Li Z; Qiu L; He L; Liang B; Liu X; Liu J
    J Mol Diagn; 2020 Aug; 22(8):1020-1029. PubMed ID: 32470556
    [TBL] [Abstract][Full Text] [Related]  

  • 53. SnapShot: CRISPR-RNA-guided adaptive immune systems.
    Carter J; Wiedenheft B
    Cell; 2015 Sep; 163(1):260-260.e1. PubMed ID: 26406380
    [TBL] [Abstract][Full Text] [Related]  

  • 54. C2c1-sgRNA Complex Structure Reveals RNA-Guided DNA Cleavage Mechanism.
    Liu L; Chen P; Wang M; Li X; Wang J; Yin M; Wang Y
    Mol Cell; 2017 Jan; 65(2):310-322. PubMed ID: 27989439
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Single-Molecule Insight Into Target Recognition by CRISPR-Cas Complexes.
    Rutkauskas M; Krivoy A; Szczelkun MD; Rouillon C; Seidel R
    Methods Enzymol; 2017; 582():239-273. PubMed ID: 28062037
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A Type I-F Anti-CRISPR Protein Inhibits the CRISPR-Cas Surveillance Complex by ADP-Ribosylation.
    Niu Y; Yang L; Gao T; Dong C; Zhang B; Yin P; Hopp AK; Li D; Gan R; Wang H; Liu X; Cao X; Xie Y; Meng X; Deng H; Zhang X; Ren J; Hottiger MO; Chen Z; Zhang Y; Liu X; Feng Y
    Mol Cell; 2020 Nov; 80(3):512-524.e5. PubMed ID: 33049228
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Battling CRISPR-Cas9 off-target genome editing.
    Li D; Zhou H; Zeng X
    Cell Biol Toxicol; 2019 Oct; 35(5):403-406. PubMed ID: 31313008
    [No Abstract]   [Full Text] [Related]  

  • 58. Chimeric DNA-RNA Guide RNA Designs.
    Lu S; Zhang Y; Yin H
    Methods Mol Biol; 2021; 2162():79-85. PubMed ID: 32926379
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Crystal Structures of Csm2 and Csm3 in the Type III-A CRISPR-Cas Effector Complex.
    Takeshita D; Sato M; Inanaga H; Numata T
    J Mol Biol; 2019 Feb; 431(4):748-763. PubMed ID: 30639408
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Direct observation of R-loop formation by single RNA-guided Cas9 and Cascade effector complexes.
    Szczelkun MD; Tikhomirova MS; Sinkunas T; Gasiunas G; Karvelis T; Pschera P; Siksnys V; Seidel R
    Proc Natl Acad Sci U S A; 2014 Jul; 111(27):9798-803. PubMed ID: 24912165
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.